- recruitingNA
Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care
This study is looking into how well a new home monitoring device works for pregnant women who need extra check-ups. It wants to see if checking your baby’s heart rate at home is easy to do and helpful for both mums and healthcare staff.
United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Phase 1 trial of LAVA-1266, a CD123-targeting bispecific Vγ9Vδ2-T cell engager, in patients with CD123 positive relapsed/refractory (R/R) acute myeloid leukemia (AML) and intermediate risk, high risk, or extremely high-risk myelodysplastic syndrome (MDS)
This early study is testing a new drug, LAVA-1266, for people over 18 with certain types of acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) that have come back or not responded to previous treatments. It aims to see if the drug is safe and what dose works best.
Spain - authorisedHuman Pharmacology (Phase I)- Other
A Multicentre, Randomised Phase Ib Trial to evaluate Neoadjuvant Immunotherapy Combination of Nivolumab alone or plus Ipilimumab with the IL-2 Superkine MDNA11 alone or with Tocilizumab in Patients with High-Risk, Surgically Resectable Melanoma – NEO-CYT
This study is for people in the UK with a type of skin cancer called high-risk melanoma that can be removed by surgery. It's testing new combinations of medicines (immunotherapy plus other drugs) before surgery to see if they can shrink the cancer and stop it from coming back.
Italy